Emma Bell

2.4k total citations
25 papers, 972 citations indexed

About

Emma Bell is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Emma Bell has authored 25 papers receiving a total of 972 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Neurology and 8 papers in Cancer Research. Recurrent topics in Emma Bell's work include Neuroblastoma Research and Treatments (11 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Epigenetics and DNA Methylation (5 papers). Emma Bell is often cited by papers focused on Neuroblastoma Research and Treatments (11 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Epigenetics and DNA Methylation (5 papers). Emma Bell collaborates with scholars based in United Kingdom, Germany and United States. Emma Bell's co-authors include Deborah A. Tweddle, John Lunec, Molly A. Taylor, Frank Westermann, Ursula R. Kees, Andrew D.J. Pearson, Tao Liu, Matthew J. Murray, Glenn M. Marshall and Nicholas Coleman and has published in prestigious journals such as Nature Communications, PLoS ONE and Development.

In The Last Decade

Emma Bell

25 papers receiving 966 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emma Bell United Kingdom 16 670 392 336 162 98 25 972
Maike Busch Germany 13 465 0.7× 247 0.6× 148 0.4× 208 1.3× 32 0.3× 40 819
Lucia Cappabianca Italy 19 570 0.9× 229 0.6× 282 0.8× 185 1.1× 26 0.3× 45 944
Anu Gupta United States 16 555 0.8× 163 0.4× 133 0.4× 160 1.0× 79 0.8× 22 954
Kristina Althoff Germany 14 547 0.8× 256 0.7× 197 0.6× 154 1.0× 21 0.2× 21 727
Paolo G. Montaldo Italy 14 447 0.7× 269 0.7× 163 0.5× 88 0.5× 41 0.4× 20 700
Marco Lodrini Germany 16 885 1.3× 219 0.6× 178 0.5× 299 1.8× 24 0.2× 24 1.1k
Lei Lü China 15 926 1.4× 140 0.4× 481 1.4× 68 0.4× 27 0.3× 29 1.1k
Antonella Tacconelli Italy 15 487 0.7× 156 0.4× 327 1.0× 232 1.4× 24 0.2× 24 820
Melanie H. Kucherlapati United States 13 566 0.8× 101 0.3× 207 0.6× 288 1.8× 55 0.6× 21 953
Ganna Oliynyk Sweden 9 418 0.6× 163 0.4× 212 0.6× 130 0.8× 40 0.4× 13 768

Countries citing papers authored by Emma Bell

Since Specialization
Citations

This map shows the geographic impact of Emma Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Bell more than expected).

Fields of papers citing papers by Emma Bell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Bell. The network helps show where Emma Bell may publish in the future.

Co-authorship network of co-authors of Emma Bell

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Bell. A scholar is included among the top collaborators of Emma Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Bell. Emma Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwalie, Petra, Emma Bell, Désirée von Tell, et al.. (2025). Innate immune response to AAV-based gene therapy vectors: Mechanisms of complement activation and cytokine release. Molecular Therapy — Methods & Clinical Development. 33(3). 101551–101551. 1 indexed citations
2.
Bell, Emma, Edward Curry, Wout Megchelenbrink, et al.. (2020). Dynamic CpG methylation delineates subregions within super-enhancers selectively decommissioned at the exit from naive pluripotency. Nature Communications. 11(1). 1112–1112. 24 indexed citations
3.
Bell, Emma, et al.. (2019). OCT4 and PAX6 determine the dual function of SOX2 in human ESCs as a key pluripotent or neural factor. Stem Cell Research & Therapy. 10(1). 122–122. 33 indexed citations
4.
Bell, Emma, et al.. (2017). A Robust Protocol to Quantify Circulating Cancer Biomarker MicroRNAs. Methods in molecular biology. 1580. 265–279. 14 indexed citations
5.
Kuchen, Erika E, Emma Bell, Chunxuan Shao, et al.. (2017). Cell-Cycle Position of Single MYC-Driven Cancer Cells Dictates Their Susceptibility to a Chemotherapeutic Drug. Cell Systems. 5(3). 237–250.e8. 52 indexed citations
6.
Henrich, Kai-Oliver, Sebastian Bender, Maral Saadati, et al.. (2016). Integrative Genome-Scale Analysis Identifies Epigenetic Mechanisms of Transcriptional Deregulation in Unfavorable Neuroblastomas. Cancer Research. 76(18). 5523–5537. 73 indexed citations
7.
Bell, Emma & Molly A. Taylor. (2016). Functional Roles for Exosomal MicroRNAs in the Tumour Microenvironment. Computational and Structural Biotechnology Journal. 15. 8–13. 70 indexed citations
8.
Shenker, Natalie, Kirsty Flower, Charlotte S. Wilhelm-Benartzi, et al.. (2015). Transcriptional implications of intragenic DNA methylation in the oestrogen receptor alpha gene in breast cancer cells and tissues. BMC Cancer. 15(1). 337–337. 14 indexed citations
9.
Curry, Edward, Nadine Chapman‐Rothe, Fanny Cherblanc, et al.. (2015). Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells. Clinical Epigenetics. 7(1). 84–84. 64 indexed citations
10.
Murray, Matthew J., Emma Bell, Katie L. Raby, et al.. (2015). A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours. British Journal of Cancer. 114(2). 151–162. 115 indexed citations
11.
Bell, Emma, Frida Ponthan, Claire Whitworth, et al.. (2014). COX2 expression in neuroblastoma increases tumorigenicity but does not affect cell death in response to the COX2 inhibitor celecoxib. Clinical & Experimental Metastasis. 31(6). 651–659. 6 indexed citations
12.
Althoff, Kristina, Anneleen Beckers, Emma Bell, et al.. (2014). A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies. Oncogene. 34(26). 3357–3368. 87 indexed citations
13.
Bell, Emma, et al.. (2014). Meeting report-3rd Neuroblastoma Research Symposium, Liverpool, 6-7th November, 2013. Pediatric Blood & Cancer. 61(9). 1711–1713. 1 indexed citations
14.
Ehemann, Volker, Gabriele Becker, Daniel Dreidax, et al.. (2013). CDK4 inhibition restores G₁-S arrest inMYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage. Cell Cycle. 12(7). 1091–1104. 52 indexed citations
15.
Bell, Emma, Frida Ponthan, Claire Whitworth, et al.. (2013). Cell Survival Signalling through PPARδ and Arachidonic Acid Metabolites in Neuroblastoma. PLoS ONE. 8(7). e68859–e68859. 27 indexed citations
16.
Bell, Emma, Gavin D. Richardson, Colin A.B. Jahoda, et al.. (2012). Dermal Stem Cells Can Differentiate Down an Endothelial Lineage. Stem Cells and Development. 21(16). 3019–3030. 5 indexed citations
17.
Bell, Emma, Lindi Chen, Tao Liu, et al.. (2010). MYCN oncoprotein targets and their therapeutic potential. Cancer Letters. 293(2). 144–157. 83 indexed citations
18.
Bell, Emma, John Lunec, & Deborah A. Tweddle. (2007). Cell Cycle Regulation Targets of MYCN Identified by Gene Expression Microarrays. Cell Cycle. 6(10). 1249–1256. 44 indexed citations
19.
Bell, Emma, Xiaohong Lü, Penny E. Lovat, et al.. (2006). The Role of MYCN in the Failure of MYCN Amplified Neuroblastoma Cell Lines to G1 Arrest After DNA Damage. Cell Cycle. 5(22). 2639–2647. 42 indexed citations
20.
Craig, Peter J., Suchira Bose, Ruud Zwart, et al.. (2004). Stable expression and characterisation of a human α7 nicotinic subunit chimera: a tool for functional high-throughput screening. European Journal of Pharmacology. 502(1-2). 31–40. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maike Busch Breakdown of academic impact, for papers by Lucia Cappabianca Breakdown of academic impact, for papers by Anu Gupta Breakdown of academic impact, for papers by Kristina Althoff Breakdown of academic impact, for papers by Paolo G. Montaldo Breakdown of academic impact, for papers by Marco Lodrini Breakdown of academic impact, for papers by Lei Lü Breakdown of academic impact, for papers by Antonella Tacconelli Breakdown of academic impact, for papers by Melanie H. Kucherlapati Breakdown of academic impact, for papers by Ganna Oliynyk
Rankless by CCL
2026